학술논문

A phase II pilot study of the efficacy and safety of nivolumab and ipilimumab in T1aN0M0 renal cell carcinoma patients ineligible for surgical treatment
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; FEB 20 2020, 38 6, 1p. Supplement: S
Subject
Language
English
ISSN
15277755